The impact of expression profiling on prognostic and predictive testing in breast cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Pathology

• Publication date

  2006-02-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jcp.2005.028324PMID 16505270PMCID PMC1860331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trial and error: prognostic gene signature study design altered.

  2005cited by this paper
• Gene expression profiling of breast cancer: a new tumor marker.

  2005cited by this paper
• Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer.

  2005cited by this paper
• Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling.

  2005cited by this paper
• Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival.

  2005cited by this paper
• Standardizing global gene expression analysis between laboratories and across platforms

  2005cited by this paper
• Mechanism-derived gene expression signatures and predictive biomarkers in clinical oncology.

  2005cited by this paper
• Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces

  2005cited by this paper
• Of fish and chips

  2005cited by this paper
• Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.

  2005influential reference
• Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt

  2005cited by this paper
• Microarrays and molecular research: noise discovery?

  2005cited by this paper
• Multiple-laboratory comparison of microarray platforms

  2005cited by this paper
• Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

  2005cited by this paper
• Prediction of docetaxel response in human breast cancer by gene expression profiling.

  2005cited by this paper
• Genomic approaches in the management and treatment of breast cancer

  2005cited by this paper
• Independence and reproducibility across microarray platforms

  2005cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005influential reference
• Prediction of cancer outcome with microarrays: a multiple random validation strategy.

  2005influential reference
• High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

  2005cited by this paper
• Comparison of gene expression measurements from cDNA and 60-mer oligonucleotide microarrays.

  2005cited by this paper
• Molecular evolution of breast cancer

  2005cited by this paper
• Gene-expression profiling in breast cancer.

  2005cited by this paper
• Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

  2005cited by this paper
• The promise of microarrays in the management and treatment of breast cancer

  2005cited by this paper
• Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays.

  2005cited by this paper
• Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer.

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Biomolecular prognostic factors in breast cancer

  2004cited by this paper
• Comprehensive comparison of six microarray technologies.

  2004cited by this paper
• Trawling for genes that predict response to breast cancer adjuvant therapy.

  2004cited by this paper
• Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds

  2004influential reference
• Getting the Noise Out of Gene Arrays

  2004cited by this paper
• Evidence-Based Use of Neoadjuvant Taxane in Operable and Inoperable Breast Cancer

  2004cited by this paper
• A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen.

  2004cited by this paper
• Mechanisms of tamoxifen resistance.

  2004cited by this paper
• Genomic Approaches to Understanding and Treating Breast Cancer

  2004cited by this paper
• Microarrays and clinical investigations.

  2004cited by this paper
• Comparison of frozen and RNALater solid tissue storage methods for use in RNA expression microarrays

  2004influential reference
• Molecular profiling of breast cancer: clinical implications

  2004cited by this paper
• Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

  2004cited by this paper
• Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer.

  2004cited by this paper
• Molecular Cytogenetic Identification of Subgroups of Grade III Invasive Ductal Breast Carcinomas with Different Clinical Outcomes

  2004cited by this paper
• Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.

  2003cited by this paper
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  2003cited by this paper
• Evaluation of gene expression measurements from commercial microarray platforms.

  2003cited by this paper
• Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis.

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

  2003cited by this paper
• Gene expression predictors of breast cancer outcomes.

  2003cited by this paper
• Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.

  2003influential reference
• Chipping away at the chip bias: RNA degradation in microarray analysis

  2003cited by this paper
• Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer.

  2003influential reference
• Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response.

  2003cited by this paper
• Predictive cancer genomics--what do we need?

  2003cited by this paper
• DNA microarrays in breast cancer: the promise of personalised medicine

  2003cited by this paper
• The biology of neoadjuvant chemotherapy for breast cancer.

  2002cited by this paper
• Analysis of matched mRNA measurements from two different microarray technologies

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Ki67 protein: the immaculate deception?

  2002cited by this paper
• Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens.

  2002cited by this paper
• Meeting highlights: International Consensus Panel on the treatment of primary breast cancer.

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Predicting the clinical status of human breast cancer by using gene expression profiles

  2001cited by this paper
• National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

  2001cited by this paper
• Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer.

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001influential reference
• Microarrays—the 21st century divining rod?

  2001cited by this paper
• Microarrays under the microscope

  2001cited by this paper
• Microarray and histopathological analysis of tumours: the future and the past?

  2001influential reference
• An introduction to arrays

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000influential reference
• Tamoxifen for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

  1995cited by this paper
• National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making

  1988cited by this paper

• Research on meat adulteration based on one-dimensional convolutional neural network (1DCNN) combined with electrochemical technology

  2024cites this paper
• Classification and survival prediction in early‐stage cirrhosis by gene expression profiling

  2022influential citation
• 68GA-PSMA PET-CT IN TRIPLE NEGATIVE METASTATIC BREAST CANCER

  2022cites this paper
• Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology

  2022cites this paper
• PET-CT COM PSMA-GA68 NO CÂNCER DE MAMA TRIPLO NEGATIVO METASTÁTICO

  2022cites this paper
• A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer.

  2021cites this paper
• Immunohistochemical expression and prognostic significance of Mortalin in invasive breast carcinoma of no special type

  2019cites this paper
• Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity

  2019cites this paper
• Prognostic Impact of EGFR and CK 5 / 6 as Basal-Markers in Triple-Negative breast Cancers

  2018cites this paper
• COMPARISON OF CLINICO-PATHOLOGICAL FEATURES AND PROGNOSIS OF TRIPLE-NEGATIVE AND NON-TRIPLE-NEGATIVE FEMALE BREAST CANCER PATIENTS

  2018cites this paper
• Ovarian ablation for premenopausal breast cancer: A review of treatment considerations and the impact of premature menopause.

  2017cites this paper
• Molecular genetics complexity impeding research progress in breast and ovarian cancers

  2017cites this paper
• An Update on Breast Cancer Biomarkers

  2017cites this paper
• Prognostic relevance of DNA flow cytometry in breast cancer revisited: The 25-year experience of the Portuguese Institute of Oncology of Lisbon.

  2017cites this paper
• INVASIVE TRIPLE NEGATIVE BREAST CANCER WITH BASAL AND NON-BASAL-LIKE IMMUNOPHENOTYPES: PROGNOSTIC IMPLICATIONS

  2017cites this paper
• DNA aneuploidy and breast cancer: a meta-analysis of 141,163 cases

  2016cites this paper
• Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerations

  2016cites this paper
• AWARD NUMBER: W81XWH-14-1-0153 TITLE: Identification of Novel Drug Targets and Lead Compounds for Advanced Prostate Cancer through Genomic and Cheminformatic Analyses PRINCIPAL INVESTIGATOR: Dr. Michael Hsing CONTRACTING ORGANIZATION: UNIVERSITY OF BRITISH COLUMBIA

  2016cites this paper
• Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma

  2016cites this paper
• Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction

  2016cites this paper
• Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications

  2016cites this paper
• Twist1 Silences Foxa1 Expression to Promote Breast Cancer Progression

  2016cites this paper
• In vitro model for DNA double‐strand break repair analysis in breast cancer reveals cell type–specific associations with age and prognosis

  2016cites this paper
• Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population

  2016cites this paper
• The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine

  2015cites this paper
• Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value

  2015cites this paper
• Estrogen-Related Receptors in Breast Cancer and Prostate Cancer

  2015cites this paper
• Molecular Pathology of Lobular Carcinoma

  2015cites this paper
• Identification of Novel Drug Targets and Lead Compounds for 5 a . CONTRACT NUMBER Advanced Prostate Cancer through Genomic and Cheminformatic Analyses

  2015cites this paper
• Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.

  2015cites this paper
• Identification of Novel Drug Targets and Lead Compounds for Advanced Prostate Cancer through Genomic and Cheminformatic Analyses

  2015cites this paper
• Triple Negative Breast Cancer: A Review of Clinicopathologic Characteristics And Treatment Options

  2014cites this paper
• Gene expression profiling of epithelial-mesenchymal transition in primary breast cancer cell culture.

  2014cites this paper
• Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers.

  2014cites this paper
• Endocrine Resistance in Breast Cancer

  2014cites this paper
• Theranostic and molecular classification of breast cancer.

  2014cites this paper
• Clinical biomarkers of response to neoadjuvant endocrine therapy in breast cancer: exploring the potential of gene expression data integration

  2013cites this paper
• Clinical study of the relationship between γ-synuclein and the response of neoadjuvant chemotherapy in breast cancer

  2013cites this paper
• A Data Similarity-Based Strategy for Meta-analysis of Transcriptional Profiles in Cancer

  2013cites this paper
• Immunohistochemical Profile and Clinical-Pathological Variants of Breast Cancer in Northeastern Mexico

  2013cites this paper
• Computational regulatory genomics: motifs, networks, and dynamics

  2012cites this paper
• Phosphorylated mTOR expression correlates with poor outcome in early-stage triple negative breast carcinomas.

  2012cites this paper
• The role of myeloid cells in breast cancer metastasis

  2012cites this paper
• Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer.

  2012cites this paper
• Reappraisal of immunohistochemical profiling of special histological types of breast carcinomas: a study of 121 cases of eight different subtypes

  2012cites this paper
• Perfil imuno-histoquímico e variáveis clinicopatológicas no câncer de mama

  2012cites this paper
• Immunohistochemical profile and clinical-pathological variables in breast cancer.

  2012cites this paper
• Apoptosis – associated genes and their role in predicting responses to neoadjuvant breast cancer treatment

  2012cites this paper
• Bevacizumab for salvage treatment of metastatic breast cancer: a systemic review and meta-analysis of randomized controlled trials

  2011cites this paper
• Genomics and proteomics of pulmonary vascular disease.

  2011cites this paper
• Regulating diagnosis in post-genomic medicine: re-aligning clinical judgment?

  2011cites this paper
• Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool?

  2011cites this paper
• Triple-negative breast cancers: an updated review on treatment options.

  2011cites this paper
• The determination of changes in the expression of genes for selected specific transcriptional factors in in vitro ductal breast cancer cells under the influence of paclitaxel

  2011cites this paper
• Pharmacogenomic-Guided Drug Development

  2011cites this paper
• Cancer: Clinical Background and Key Challenges

  2011cites this paper
• Genomic Applications to Study Pulmonary Hypertension

  2011cites this paper
• Immunohistochemistry and Molecular Biology of Breast Cancers: Old and New Prognostic Factors

  2011cites this paper
• Expressão de CD44 e CD24 em carcinomas mamários ductais invasivos de acordo com análise dos subtipos moleculares e sua relação com fatores prognósticos

  2011cites this paper
• Tipos especiais histológicos de carcinomas da mama : perfil imunoistoquímico com ênfase na classificação molecular

  2011cites this paper
• Basal-like breast carcinoma: a phenotypically distinct entity.

  2010cites this paper
• The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade

  2010influential citation
• Triple-Negative Breast Cancer: A Short Review

  2010cites this paper
• Triple negative breast cancer: from molecular portrait to therapeutic intervention.

  2010cites this paper
• Genomics of pulmonary arterial hypertension: implications for therapy.

  2010cites this paper
• From conventional pathologic diagnosis to the molecular classification of breast carcinoma: are we ready for the change?

  2009cites this paper
• Molecular Classification of Breast Carcinomas by Immunohistochemical Analysis: Are We Ready?

  2009cites this paper
• Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome

  2009cites this paper
• Genomweite Expressionsprofile als klinische Entscheidungshilfe

  2009cites this paper
• Microarray-based Gene Expression Profiling as a Clinical Tool for Breast Cancer Management: Are We There Yet?

  2009influential citation
• SOCIETY COMPANION MEETING : DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY

  2009cites this paper
• Toward theragnostics

  2009cites this paper
• High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy.

  2009cites this paper
• The role of molecular analysis in breast cancer

  2009cites this paper
• Quality control in microarray assessment of gene expression in human airway epithelium

  2009cites this paper
• Communicating Results of New Genomic Tests to Physicians

  2009cites this paper
• Distribution of Molecular Breast Cancer Subtypes in Middle Eastern-Saudi Arabian Women: A Pilot Study

  2009cites this paper
• Genetic characterization of breast cancer and implications for clinical management

  2009cites this paper
• From Expression Profiling to Routine Practice

  2009cites this paper
• Distribution of molecular breast cancer subtypes in middle eastern-saudi arabian women: a pilot study.

  2009cites this paper
• Gene Expression Profiling in Breast Cancer

  2009cites this paper
• Creating and evaluating genetic tests predictive of drug response

  2009cites this paper
• Triple negative and basal-like breast cancer : one or many diseases ? Implications for surgical pathologists

  2009cites this paper
• Molecular Markers of Tumors

  2009cites this paper
• Ключевые слова: биологические маркеры опухолей, рецепторы стероидных гормонов, факторы роста, ре- цепторы факторов роста, протеинкиназы, опухоль-ассоциированные протеазы, маркеры ангиогенеза, микрочипы.

  2009cites this paper
• Development of new knowledge discovery tools to explore biomedical datasets in breast cancer

  2009cites this paper
• [Genome-wide expression profiling as a clinical tool: are we there yet?].

  2009cites this paper
• Basal-like breast carcinoma: from expression profiling to routine practice.

  2009cites this paper
• Immunohistochemical expression and significance of epidermal growth factor receptor (EGFR) in breast cancer.

  2009cites this paper
• Prognostische und prädiktive Faktoren invasiver Mammakarzinome

  2009cites this paper
• Technological challenges of theranostics in oncology.

  2009cites this paper
• Pathologie des invasiven Mammakarzinoms

  2008cites this paper
• MicroRNAs and their potential

  2008cites this paper
• Segmentation of cDNA microarray images by kernel density estimation

  2008cites this paper
• Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study

  2008influential citation
• Comparative expression analysis of four breast cancer subtypes versus matched normal tissue from the same patients.

  2008cites this paper
• Clinical and pathologic aspects of basal-like breast cancers

  2008cites this paper
• A gene sets approach for identifying prognostic gene signatures for outcome prediction

  2008cites this paper
• Clinical Genomics in Oncology

  2008cites this paper
• Action des hormones stéroïdiennes sur le transcriptome de la glande mammaire chez la souris

  2008cites this paper